The role of empagliflozin-induced metabolic changes for cardiac function in patients with type 2 diabetes. A randomized cross-over magnetic resonance imaging study with insulin as comparator

The role of empagliflozin-induced metabolic changes for cardiac function in patients with type 2 diabetes. A randomized cross-over magnetic resonance imaging study with insulin as comparator

Abstract Background Metabolic effects of empagliflozin treatment include lowered glucose and insulin concentrations, elevated free fatty acids and ketone bodies and have been suggested to contribute to the cardiovascular benefits of empagliflozin treatment, possibly through an improved cardiac funct...

Full description

Bibliographic Details
Main Authors: Roopameera Thirumathyam, Erik Arne Richter, Gerrit van Hall, Jens Juul Holst, Mogens Fenger, Jens P. Gøtze, Ulrik Dixen, Niels Vejlstrup, Sten Madsbad, Per Lav Madsen, Nils Bruun Jørgensen
Format: Article
Language:English
Published: BMC 2024-01-01
Series:Cardiovascular Diabetology
Subjects:
Sodium-glucose linked transporter 2 inhibition
Cardiac function
Metabolism
Type 2 diabetes
Hyperinsulinemia
Online Access:https://doi.org/10.1186/s12933-023-02094-x

Internet

https://doi.org/10.1186/s12933-023-02094-x

Similar Items